Orchard Therapeutics plc - ADR

Orchard Therapeutics plc - ADR

ORTX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$380.11M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Orchard Therapeutics plc - ADROrchard Therapeutics plc - ADR-27.4-87%-0.6
$17.15

Current Fair Value

2.7% upside

Undervalued by 2.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$380.11 Million
Enterprise Value$405.20 Million
Earnings per Share$-0.61
Beta0.55
Outstanding Shares22,838,856

Return

Return on Equity87.04%ROE
Return on Assets34.54%
Return on Invested Capital40.55%

Valuation & Multiples

P/E Ratio-27.38P/E Ratio
PEG106.34PEG
Price to Sales-Price to Sales
Price to Book Ratio5.57Price to Book Ratio
Enterprise Value to Revenue18.55
Enterprise Value to EBIT6.54
Enterprise Value to Net Income5
Total Debt to Enterprise0.12
Debt to Equity0.61Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Orchard Therapeutics plc

Orchard Therapeutics plc Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.